Project description
Researcher training in glyco-immune checkpoints
At the molecular and dynamic level, how do interactions between the immunomodulatory receptors Siglecs and their sialylated cognate ligands contribute to the aetiology of immune-related diseases like cancer? Is it possible to tune this axis to provide new therapeutic approaches? These are questions the EU-funded GLYTUNES project seeks to answer through a multidisciplinary European training network on glyco-immune checkpoints. Specifically, it will address the main priorities concerning the use of innovative methodological, interdisciplinary approaches for the treatment of human diseases. Guided by leaders in their respective fields of research, GLYTUNES involves seven academic partners and four companies (SMEs) from seven European countries. The programme will train 14 early-stage researchers.
Fields of science
Programme(s)
Coordinator
80138 Napoli
Italy
See on map
Participants (10)
NR4 7UQ Norwich
See on map
48160 Derio Vizcaya
See on map
1081 HV Amsterdam
See on map
50121 Florence
See on map
75794 Paris
See on map
6525 XZ Nijmegen
See on map
48160 Derio
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
NR4 7GJ Norwich
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
14476 Potsdam
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
50019 Sesto Fiorentino Fi
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.